Connect with us

Published

on

Andrew Hitz with the Zeus hand.

Courtesy of Aether Biomedical

In 2011, Jeremy Schroeder was driving a four-wheeler near Sherwood, Ohio, when he crashed into a stop sign he hadn’t seen as the stone path suddenly turned to asphalt. The sign left a deep gash in Schroeder’s arm; he was rapidly losing blood. 

Shroeder, who was 30 at the time, waited more than an hour for emergency medical services to arrive before he was finally airlifted to a nearby hospital.

When he woke up in a room across from his anxious wife, Schroeder was missing a hand. 

“She goes, ‘I got bad news,'” he told CNBC in an interview, recalling the conversation. 

Schroeder’s left arm was amputated around five inches below his elbow. He has four kids and manages a small farm where he drives tractors, harvests crops and cares for animals, so he was determined not to let his accident slow him down. 

Now, 12 years later, Schroeder wears a bionic hand designed by the startup Aether Biomedical, and it’s business as usual for him. Aether’s hand, called the Zeus, can lift up to 77 pounds and switch between 12 different customizable grip patterns in real time. Schroeder, who is now an ambassador for the company, said he uses it for “everything,” whether it’s carrying groceries, driving his truck or caring for his kids.  

Founded in 2018, Aether is based in Poland with U.S. headquarters in Chicago. Aether works with upper limb amputees, and anyone with an amputation level between the wrist and the shoulder can use its Zeus hand. Once patients are fitted with a prosthetic socket for their arm by a doctor, Aether’s device can fasten on the end.

More than 200 patients are using Aether’s Zeus hand, and like other bionic hands, it works by translating the electrical signals in the arm muscles. When a patient thinks of a grip like holding a bottle or pinching a needle, Aether’s sensors detect these electrical signals and its software converts them into actions. 

“Just about anything you can think, you can do,” Schroeder said. “It’s really neat what some people can do with it.”

Jeremy Schroeder with the Zeus hand.

Courtesy of Aether Biomedical

Aether CEO Dhruv Agrawal said the Zeus hand is the strongest bionic hand on the market, and it’s also the only hand that can be remotely configured through an app, which is a big selling point for users.

It’s common for patients to need adjustments to their bionic devices, especially as they are first learning to use them, and it usually requires an in-person visit to a doctor’s office. But patients who use Aether’s device can have their clinician log on to the company’s cloud-based platform and reconfigure grip patterns and make other adjustments remotely. 

Schroeder said this feature often saves him more than two hours of driving.

Aether also takes a unique approach to larger repairs. 

The Zeus hand is made up of seven modules that can be easily replaced at a doctor’s office, said Sarra Mullen, head of U.S. operations at Aether. She said other bionic hands have to be sent back to the manufacturers to be repaired, which can leave patients stuck without their devices for extended periods. 

“Imagine not having your hand for weeks, months at a time,” Mullen told CNBC in an interview. “We have this ability now to keep the device on the patient at all times, and that truly is remarkable.”

Aether’s Zeus hand is approved by the U.S. Food and Drug Administration, and it’s covered by all major insurance payers. Aether said the cost of the Zeus hand will vary depending on the person. The company generates revenue, Mullen said, so its main focus is on scaling access to its technology.  

On Monday, Aether announced it closed a $5.8 million funding round led by J2 Ventures and Story Ventures. Agrawal said the funding will mainly be used to improve the company’s manufacturing process. Aether currently has a backlog of devices it needs to ship out, he added. 

In the U.S. alone, there are between 800,000 and 1 million estimated upper limb amputees, so there is plenty of room for Aether to grow. The challenge, Agrawal said, is winning over patients who have never wanted a bionic hand or who have been discouraged by past devices they’ve tried.    

“If you used a device many years ago and didn’t like it, that doesn’t mean that you have to give up on it today,” he told CNBC in an interview. “Technology is improving.” 

Given Aether’s presence in Poland, Agrawal said the company is also working to get its devices to people who have been injured because of the war in Ukraine. He said Aether is sending its first team to the region in a few weeks, and the company is expecting to fit between 300 to 500 people with the Zeus hand over the next year and a half.

Patients need to practice

The Zeus hand.

Courtesy of Aether Biomedical

If patients have never used a bionic hand before, Mullen said, it usually takes between four to six weeks to learn how to use Aether’s comfortably. She said patients first generally see a prosthetist, which is the kind of doctor that fits patients with artificial limbs. They get set up with the hand, and then go to occupational therapy to learn to use it.   

It takes time and practice to understand how to operate the different grip patterns, Mullen said. But Andrew Hitz, a 61-year-old who lives about 40 miles south of Dallas, mastered the Zeus hand in just 10 minutes. 

Hitz had an elective amputation below the elbow of his left arm in February of 2019 after suffering a serious accident on a side-by-side vehicle years earlier. He had tried to save his hand through a number of different procedures, and his surgeon eventually told him that he was out of options.  

“Actually, it was the best thing that I ever did,” Hitz told CNBC in an interview. “I wish I would have jumped to the conclusion of having it taken off years prior, saving me some of the agony and pain of all the surgeries that I went through.”

Hitz has used other bionic hands before, and he said many of them are sitting on his shelf and collecting dust. He happened to stumble across Aether at a trade show in Dallas this year where tried out the Zeus hand. He said using it for the first time was like a “ray of bright sunshine.”

“Literally in 10 minutes I was picking up little blocks that this previous hand that I had for almost a year and a half I just never mastered,” he said. 

Aether gave Hitz a hand for free, and he is now an ambassador for the company.

Like Schroeder, Hitz lives a very hands-on lifestyle and manages a small farm with his wife. He cares for chickens, sheep, goats, donkeys and more. He said the Zeus hand works great for holding rakes and shovels, driving his tractor, carrying feed and gathering hay.

Hitz said the Zeus hand also has a soft grip feature, which means he can use it to pick up eggs from his chicken coop. 

“If I would have tried that with my other two, it would have smushed all over the place, egg everywhere,” Hitz said. “So that just blew my mind when I went up to the chicken coop, and I did not crush that egg.” 

Out of Aether’s 50 employees, Agrawal said around 75% are dedicated to research and development, so the company is always looking ahead to what is next. He said Aether is already working on next generation devices, as well as better machine learning systems and digital training platforms. 

He said ultimately, Aether’s goal is to help make bionic devices more accessible and easier to use.

“The amount of mental taxation that a user has to put in to use these devices has decreased a lot with our product,” he said. “And I think that is really key to ensuring that these devices don’t sit in a boardroom, but are actually used by patients.”

Continue Reading

Technology

Trump advisor Navarro rips Apple’s Tim Cook for not moving production out of China fast enough

Published

on

By

Trump advisor Navarro rips Apple's Tim Cook for not moving production out of China fast enough

Peter Navarro: 'Inconceivable' that Apple could not produce iPhones outside China

White House trade advisor Peter Navarro chastised Apple CEO Tim Cook on Monday over the company’s response to pressure from the Trump administration to make more of its products outside of China.

“Going back to the first Trump term, Tim Cook has continually asked for more time in order to move his factories out of China,” Navarro said in an interview on CNBC’s “Squawk on the Street.” “I mean it’s the longest-running soap opera in Silicon Valley.”

CNBC has reached out to Apple for comment on Navarro’s criticism.

President Donald Trump has in recent months ramped up demands for Apple to move production of its iconic iPhone to the U.S. from overseas. Apple’s flagship phone is produced primarily in China, but the company has increasingly boosted production in India, partly to avoid the higher cost of Trump’s tariffs.

Trump in May warned Apple would have to pay a tariff of 25% or more for iPhones made outside the U.S. In separate remarks, Trump said he told Cook, “I don’t want you building in India.”

Read more CNBC tech news

Analysts and supply chain experts have argued it would be impossible for Apple to completely move iPhone production to the U.S. By some estimates, a U.S.-made iPhone could cost as much as $3,500.

Navarro said Cook isn’t shifting production out of China quickly enough.

“With all these new advanced manufacturing techniques and the way things are moving with AI and things like that, it’s inconceivable to me that Tim Cook could not produce his iPhones elsewhere around the world and in this country,” Navarro said.

Apple currently makes very few products in the U.S. During Trump’s first term, Apple extended its commitment to assemble the $3,000 Mac Pro in Texas.

In February, Apple said it would spend $500 billion within the U.S., including on assembling some AI servers.

WATCH: Apple’s $500 billion investment: For AI servers not manufacturing iPhones

Apple's $500 billion U.S. investment: For AI servers not manufacturing iPhones

Continue Reading

Technology

CoreWeave to acquire Core Scientific in $9 billion all-stock deal

Published

on

By

CoreWeave to acquire Core Scientific in  billion all-stock deal

CoreWeave founders Brian Venturo, at left in sweatshirt, and Mike Intrator slap five after ringing the opening bell at Nasdaq headquarters in New York on March 28, 2025.

Michael M. Santiago | Getty Images News | Getty Images

Artificial intelligence hyperscaler CoreWeave said Monday it will acquire Core Scientific, a leading data center infrastructure provider, in an all-stock deal valued at approximately $9 billion.

Coreweave stock fell about 4% on Monday while Core Scientific stock plummeted about 20%. Shares of both companies rallied at the end of June after the Wall Street Journal reported that talks were underway for an acquisition.

The deal strengthens CoreWeave’s position in the AI arms race by bringing critical infrastructure in-house.

CoreWeave CEO Michael Intrator said the move will eliminate $10 billion in future lease obligations and significantly enhance operating efficiency.

The transaction is expected to close in the fourth quarter of 2025, pending regulatory and shareholder approval.

Read more CNBC tech news

The deal expands CoreWeave’s access to power and real estate, giving it ownership of 1.3 gigawatts of gross capacity across Core Scientific’s U.S. data center footprint, with another gigawatt available for future growth.

Core Scientific has increasingly focused on high-performance compute workloads since emerging from bankruptcy and relisting on the Nasdaq in 2024.

Core Scientific shareholders will receive 0.1235 CoreWeave shares for each share they hold — implying a $20.40 per-share valuation and a 66% premium to Core Scientific’s closing stock price before deal talks were reported.

After closing, Core Scientific shareholders will own less than 10% of the combined company.

Continue Reading

Technology

Apple appeals 500 million euro EU fine over App Store policies

Published

on

By

Apple appeals 500 million euro EU fine over App Store policies

Two young men stand inside a shopping mall in front of a large illuminated Apple logo seen through a window in Chongqing, China, on June 4, 2025.

Cheng Xin | Getty Images

Apple on Monday appealed what it called an “unprecedented” 500 million euro ($586 million) fine issued by the European Union for violating the bloc’s Digital Markets Act.

“As our appeal will show, the EC [European Commission] is mandating how we run our store and forcing business terms which are confusing for developers and bad for users,” the company said in a statement. “We implemented this to avoid punitive daily fines and will share the facts with the Court.”

Apple recently made changes to its App Store‘s European policies that the company said would be in compliance with the DMA and would avoid the fines.

The Commission, which is the executive body of the EU, announced its fine in April, saying that Apple “breached its anti-steering obligation” under the DMA with restrictions on the App Store.

Read more CNBC tech news

“Due to a number of restrictions imposed by Apple, app developers cannot fully benefit from the advantages of alternative distribution channels outside the App Store,” the commission wrote. “Similarly, consumers cannot fully benefit from alternative and cheaper offers as Apple prevents app developers from directly informing consumers of such offers.”

Under the DMA, tech giants like Apple and Google are required to allow businesses to inform end-users of offers outside their platform — including those at different prices or with different conditions.

Companies like Epic Games and Spotify have complained about restrictions within the App Store that make it harder for them to communicate alternative payment methods to iOS users.

Apple typically takes a 15%-30% cut on in-app purchases.

Continue Reading

Trending